Magrilan

Fluoxetine, the active ingredient in Magrilan, is a selective serotonin reuptake inhibitor (SSRI) presented as an oral tablet for oral use. It is prescribed to treat major depressive disorder and several related psychiatric conditions in adult patients.

GNH USA supplies Magrilan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Our global distribution network ensures timely delivery and compliance with local regulatory requirements.

Fluoxetine is used to treat several psychiatric disorders by modulating serotonin pathways. - Major depressive disorder: reduces depressive symptoms and improves mood. - Obsessive‑compulsive disorder: lessens intrusive thoughts and compulsive behaviors. - Panic disorder: decreases frequency and severity of panic attacks. - Bulimia nervosa: helps reduce binge‑eating episodes and associated urges. - Premenstrual dysphoric disorder: alleviates mood swings and physical symptoms linked to the menstrual cycle.

Fluoxetine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Headache: transient cranial discomfort. - Insomnia: difficulty falling or staying asleep. - Dry mouth: reduced salivation. - Sexual dysfunction: decreased libido or delayed orgasm. - Diarrhea: loose stools.

Serious or Rare Side Effects: - Serotonin syndrome: agitation, hyperthermia, and neuromuscular abnormalities. - Suicidal thoughts: increased risk especially in young adults. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Hyponatremia: low blood sodium causing confusion. - QT prolongation: cardiac rhythm disturbances.

When prescribing fluoxetine, clinicians should consider several safety precautions to minimize risks. - Assess for suicidal ideation: monitor patients, especially during early treatment and dose changes. - Evaluate hepatic function: adjust use in patients with severe liver impairment. - Review psychiatric history: caution in bipolar disorder due to risk of mania. - Avoid abrupt discontinuation: taper gradually to prevent discontinuation syndrome. - Consider drug interactions: check concomitant serotonergic agents and CYP2D6 inhibitors. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Fluoxetine interacts with several medicines; understanding the interaction level guides clinical decisions.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome if combined. - Thioridazine or pimozide: can cause cardiac arrhythmias and increased plasma levels.

Moderate Interactions (Monitor Closely): - NSAIDs: increased bleeding risk. - Warfarin: enhanced anticoagulant effect, monitor INR. - Oral contraceptives: reduced efficacy, consider alternative contraception. - Alcohol: may intensify central nervous system effects.